Financial Statements

Key Data by Segment

Key Data by Segment[Table 27]
  HealthCare CropScience MaterialScience     Reconciliation    
  Pharmaceuticals Consumer Health CropScience MaterialScience All Other Segments Corporate Center
and Consolidation
Group
  2nd Quarter 2014 2nd Quarter 2015 2nd Quarter 2014 2nd Quarter 2015 2nd Quarter 2014 2nd Quarter 2015 2nd Quarter 2014 2nd Quarter 2015 2nd Quarter 2014 2nd Quarter 2015 2nd Quarter 2014 2nd Quarter 2015 2nd Quarter 2014 2nd Quarter 2015
  € million € million € million € million € million € million € million € million € million € million € million € million € million € million
Net sales (external) 2,960 3,492 1,655 2,416 2,470 2,723 2,864 3,185 275 273 4 1 10,228 12,090
Change +4.6% +18.0% -2.5% +46.0% +3.3% +10.2% -0.4% +11.2% -5.8% -0.7% +1.4% +18.2%
Currency-adjusted change +10.6% +10.7% +4.1% +36.8% +10.5% +0.2% +3.2% +0.6% -4.8% +0.4% +7.0% +9.2%
Intersegment sales 36 8 4 16 9 15 14 553 590 (624) (621)
Net sales (total) 2,996 3,500 1,659 2,416 2,486 2,732 2,879 3,199 828 863 (620) (620) 10,228 12,090
EBIT 656 706 271 362 470 571 109 278 35 24 (106) (108) 1,435 1,833
EBIT before special items 668 780 284 433 470 599 126 337 41 40 (106) (101) 1,483 2,088
EBITDA before special items 927 1,077 387 598 615 733 270 506 82 84 (105) (99) 2,176 2,899
Gross cash flow1 662 720 258 411 469 537 214 359 139 219 (77) (73) 1,665 2,173
Net cash flow1 292 433 173 304 971 742 133 360 52 85 (52) 26 1,569 1,950
Depreciation, amortization and impairments 263 301 103 164 145 134 147 170 41 44 1 2 700 815
 
  1st Half 2014 1st Half 2015 1st Half 2014 1st Half 2015 1st Half 2014 1st Half 2015 1st Half 2014 1st Half 2015 1st Half 2014 1st Half 2015 1st Half 2014 1st Half 2015 1st Half 2014 1st Half 2015
Net sales (external) 5,742 6,692 3,242 4,720 5,370 5,815 5,667 6,199 554 541 5 2 20,580 23,969
Change +6.4% +16.5% -2.8% +45.6% +4.2% +8.3% +0.3% +9.4% -3.7% -2.3% +2.3% +16.5%
Currency-adjusted change +13.1% +9.0% +3.9% +37.0% +11.3% +0.9% +3.7% -0.7% -2.8% -2.3% +8.0% +8.3%
Intersegment sales 43 18 4 31 19 28 27 1,072 1,130 (1,178) (1,194)
Net sales (total) 5,785 6,710 3,246 4,720 5,401 5,834 5,695 6,226 1,626 1,671 (1,173) (1,192) 20,580 23,969
EBIT 1,297 1,397 561 657 1,458 1,445 328 497 59 43 (203) (262) 3,500 3,777
EBIT before special items 1,293 1,495 574 849 1,458 1,520 347 598 72 65 (203) (251) 3,541 4,276
EBITDA before special items 1,800 2,065 780 1,166 1,713 1,773 636 930 151 154 (201) (248) 4,879 5,840
Gross cash flow1 1,236 1,410 535 774 1,239 1,242 499 671 321 268 (147) (181) 3,683 4,184
Net cash flow1 739 1,185 366 769 249 (81) 89 523 200 57 70 174 1,713 2,627
Depreciation, amortization and impairments 511 574 206 338 255 258 292 354 79 89 2 3 1,345 1,616
Number of employees (as of June 30)2 38,834 39,994 16,579 18,664 22,222 23,856 14,128 15,071 20,035 19,482 758 731 112,556 117,798
2014 figures restated
1
For definition see Chapter 8 “Financial Position of the Bayer Group.”
2
Full-time equivalents
Last updated: July 29, 2015  Copyright © Bayer AG
http://www.quarterly-report-2015-q2.bayer.com